New Commercial Supply Contracts for Vafseo® (vadadustat) secured, bringing availability and dialysis organization coverage to nearly 100% of patients on dialysis in U.S. Akebia Therapeutics ...

https://www.tipranks.com/news/the-fly/akebia-announces-multiple-positive-business-updates Akebia (AKBA) Therapeutics announced multiple positive business updates. As ...

CAMBRIDGE, Mass., Jan. 13, 2025 /PRNewswire/ -- Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease ...

Akebia (AKBA) Therapeutics announced multiple positive business updates. As of January, Vafseo tablets are available in the U.S. for adult patients with anemia due to chronic kidney disease on ...

Analyst Ed Arce of H.C. Wainwright maintained a Buy rating on Akebia Therapeutics (AKBA – Research Report), retaining the price target of $7.50. Discover outperforming stocks and invest smarter ...

Akebia received feedback from the U.S. Food and Drug Administration (FDA) on its protocol submission for a label expansion study and is incorporating feedback as appropriate. Akebia expects to begin ...

2 Auxiliary Fuel Tanks (ACTs) for over 4000 nm of range non-stop (Middle East to Europe - Europe to US East Coast – Asia to Middle East) ...

SEC Filings provided by EDGAR Online, Inc.

The Donation Gateway that powers the Plant-for-the-Planet Platform. You can make donations to restoration organizations, plant trees and support forest conservation.

Since we subscribed to Business Sale Report, our M&A activity has increased several fold, and been made much more easy. Generally a very useful publication. An exceptional opportunity to acquire a ...